CEP170p1: A Potential Drug Target for Cancer (G645455)
CEP170p1: A Potential Drug Target for Cancer
Centrosomal protein 170 (CEP170) is a protein that is expressed in a variety of cell types, including neurons and cancer cells. It is a key component of the centrosome, which is a structure that is present in the nucleus of eukaryotic cells. The centrosome plays a crucial role in the proper functioning of cell division and has been implicated in a number of diseases, including cancer.
One of theCEP170p1's functions is to help regulate cell division. It is a key regulator of the spindle formation and stability and plays an important role in mitosis. Mutations in CEP170p1 can lead to chromosomal instability, thereby increasing the likelihood of cancer.
In addition, CEP170p1 also has other biological functions. For example, it is associated with neuronal survival and apoptosis. In neurons, the activity of CEP170p1 has been shown to be related to neuronal survival and apoptosis. In addition, CEP170p1 is also related to the cell cycle and plays an important role in the mitotic cycle.
In addition, CEP170p1 is also related to the occurrence and development of tumors. Studies have shown that the expression level of CEP170p1 is closely related to the prognosis and treatment response of various cancers. Therefore, CEP170p1 can be used as a potential drug target or biomarker to treat cancer.
Finally, the study of CEP170p1 also helps us gain a deeper understanding of cell biology. The structure and function of CEP170p1 can be studied through experimental methods, such as protein electrophoresis, Western blotting, immunohistochemistry, etc. These findings can provide an important theoretical basis for the development of new treatment strategies.
In conclusion, CEP170p1 is a protein that plays a crucial role in the functioning of cells. Its functions include regulating cell division, participating in the regulation of neural survival and apoptosis, and being involved in the development and progression of cancer. Therefore, CEP170p1 may be a valuable drug target or biomarker for the treatment of cancer. Further research is needed to fully understand its role and potential as a therapeutic agent.
Protein Name: Centrosomal Protein 170 Pseudogene 1
More Common Targets
CEP19 | CEP192 | CEP20 | CEP250 | CEP290 | CEP295 | CEP295NL | CEP350 | CEP350-FGFR1OP-MAPRE1 complex | CEP41 | CEP43 | CEP44 | CEP55 | CEP57 | CEP57L1 | CEP63 | CEP68 | CEP70 | CEP72 | CEP72-DT | CEP76 | CEP78 | CEP83 | CEP83-DT | CEP85 | CEP85L | CEP89 | CEP95 | CEP97 | CEPT1 | CER1 | Ceramidase | Ceramide synthase | CERCAM | CERK | CERKL | CERNA2 | CERS1 | CERS2 | CERS3 | CERS3-AS1 | CERS4 | CERS5 | CERS6 | CERS6-AS1 | CERT1 | CES1 | CES1P1 | CES1P2 | CES2 | CES3 | CES4A | CES5A | CETN1 | CETN2 | CETN3 | CETN4P | CETP | CFAP100 | CFAP100-DT | CFAP107 | CFAP119 | CFAP126 | CFAP141 | CFAP157 | CFAP161 | CFAP20 | CFAP206 | CFAP20DC | CFAP20DC-AS1 | CFAP20DC-DT | CFAP210 | CFAP221 | CFAP251 | CFAP276 | CFAP298 | CFAP299 | CFAP300 | CFAP36 | CFAP410 | CFAP418 | CFAP418-AS1 | CFAP43 | CFAP44 | CFAP44-AS1 | CFAP45 | CFAP46 | CFAP47 | CFAP52 | CFAP53 | CFAP54 | CFAP57 | CFAP58 | CFAP61 | CFAP65 | CFAP68 | CFAP69 | CFAP70 | CFAP73 | CFAP74